source
- Biotech boards see more women, but CEO roles remain largely male-dominatedWomen now occupy roughly 29% of biotech board seats, a notable rise from about one‑fifth a few years ago, according to the latest Bedford Group Transearch report. Despite that progress, female CEO…
- Lilly signs $5.9B deal with Stipple to unlock oncology targetsEli Lilly has struck a $5.9 billion deal to partner with Stipple Bio on oncology drug candidates that more precisely target tumor cells.Fierce Biotech · 7h ago↗ source
- IQVIA report finds 90% of drugs launched 2016-2020 unlikely to recoup costs